Lumos Pharma Inc.

NASDAQ: LUMO · Real-Time Price · USD
4.34
0.00 (0.00%)
At close: Dec 11, 2024, 10:00 PM

Lumos Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-34.03M -31.06M -30.43M
Depreciation & Amortization
44K 49K 203K
Stock-Based Compensation
2.32M 2.32M 2.88M
Other Working Capital
679K 400K -950K
Other Non-Cash Items
-392K -26K 14K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
965K 2.1M -2.31M
Operating Cash Flow
-31.09M -26.62M -29.65M
Capital Expenditures
n/a -21K -30K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-7.38M -11.34M n/a
Sales Maturities Of Investments
18.12M n/a n/a
Other Investing Acitivies
n/a -11.34M 26M
Investing Cash Flow
10.74M -11.36M 25.97M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
-1.31M -675K -114K
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
9K -146K -114K
Financial Cash Flow
-576K -821K -192K
Net Cash Flow
-20.93M -38.8M -3.87M
Free Cash Flow
-31.09M -26.64M -29.68M